95 related articles for article (PubMed ID: 22350865)
1. Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction.
Thrift AP; Nagle CM; Fahey PP; Smithers BM; Watson DI; Whiteman DC
Cancer Causes Control; 2012 Apr; 23(4):555-64. PubMed ID: 22350865
[TBL] [Abstract][Full Text] [Related]
2. Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction.
Olsen CM; Pandeya N; Green AC; Webb PM; Whiteman DC;
Am J Epidemiol; 2011 Sep; 174(5):582-90. PubMed ID: 21719746
[TBL] [Abstract][Full Text] [Related]
3. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.
Sundelöf M; Lagergren J; Ye W
Eur J Cancer; 2008 Jul; 44(11):1566-71. PubMed ID: 18434132
[TBL] [Abstract][Full Text] [Related]
4. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival.
Thrift AP; Nagle CM; Fahey PP; Russell A; Smithers BM; Watson DI; Whiteman DC;
Int J Cancer; 2012 Sep; 131(5):E759-68. PubMed ID: 22213172
[TBL] [Abstract][Full Text] [Related]
5. Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men.
Levi Z; Kark JD; Shamiss A; Derazne E; Tzur D; Keinan-Boker L; Liphshitz I; Niv Y; Furman M; Afek A
Cancer; 2013 Dec; 119(23):4086-93. PubMed ID: 24129941
[TBL] [Abstract][Full Text] [Related]
6. Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.
Agarwal S; Bell MG; Dhaliwal L; Codipilly DC; Dierkhising RA; Lansing R; Gibbons EE; Leggett CL; Kisiel JB; Iyer PG
Dig Dis Sci; 2024 Jan; 69(1):246-253. PubMed ID: 37914889
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?
Eloubeidi MA; Mason AC; Desmond RA; El-Serag HB
Am J Gastroenterol; 2003 Jul; 98(7):1627-33. PubMed ID: 12873590
[TBL] [Abstract][Full Text] [Related]
8. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus.
Pandeya N; Williams GM; Sadhegi S; Green AC; Webb PM; Whiteman DC
Am J Epidemiol; 2008 Jul; 168(1):105-14. PubMed ID: 18483122
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas.
Whitson BA; Groth SS; Li Z; Kratzke RA; Maddaus MA
J Thorac Cardiovasc Surg; 2010 Jan; 139(1):43-8. PubMed ID: 19660401
[TBL] [Abstract][Full Text] [Related]
10. Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; Reitsma JB; Ten Kate FJ; Busch OR; Obertop H; Zwinderman AH; Moons J; van Lanschot JJ; Lerut T
Ann Surg; 2008 Dec; 248(6):1006-13. PubMed ID: 19092345
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
[TBL] [Abstract][Full Text] [Related]
12. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
[TBL] [Abstract][Full Text] [Related]
13. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence.
Lagarde SM; de Boer JD; ten Kate FJ; Busch OR; Obertop H; van Lanschot JJ
Ann Surg; 2008 Jan; 247(1):71-6. PubMed ID: 18156925
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.
Duhaylongsod FG; Wolfe WG
J Thorac Cardiovasc Surg; 1991 Jul; 102(1):36-41; discussion 41-2. PubMed ID: 2072727
[TBL] [Abstract][Full Text] [Related]
15. Surveillance and follow-up strategies in patients with high-grade dysplasia in Barrett's esophagus: a Dutch population-based study.
Verbeek RE; van Oijen MG; ten Kate FJ; Vleggaar FP; Schipper ME; Casparie MK; van Baal JW; Siersema PD
Am J Gastroenterol; 2012 Apr; 107(4):534-42. PubMed ID: 22270082
[TBL] [Abstract][Full Text] [Related]
16. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
Sadeghi S; Bain CJ; Pandeya N; Webb PM; Green AC; Whiteman DC;
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1169-78. PubMed ID: 18483339
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
18. Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?
Solomon NL; Cheung MC; Byrne MM; Zhuge Y; Franceschi D; Livingstone AS; Koniaris LG
Ann Surg Oncol; 2010 Jan; 17(1):98-108. PubMed ID: 19777191
[TBL] [Abstract][Full Text] [Related]
19. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
Reynolds JV; Donohoe CL; McGillycuddy E; Ravi N; O'Toole D; O'Byrne K; Hollywood D
J Thorac Cardiovasc Surg; 2012 May; 143(5):1130-1137.e1. PubMed ID: 22244551
[TBL] [Abstract][Full Text] [Related]
20. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?
Gertler R; Stein HJ; Loos M; Langer R; Friess H; Feith M
Am J Surg Pathol; 2011 Oct; 35(10):1512-22. PubMed ID: 21934477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
